Brief: Apollomics Announces Approval Of Vebreltinib In China
25/04/2024 14:15
April 25 (Reuters) - Apollomics Inc APLM.O :
* APOLLOMICS ANNOUNCES APPROVAL OF VEBRELTINIB IN CHINA AS A
FIRST-IN-CLASS TREATMENT FOR GLIOMAS WITH MET FUSION GENE
Source text for Eikon: ID:nGNX7W4K81
Further company coverage: APLM.O
((Reuters.Briefs@thomsonreuters.com;))